CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Aptalis Pharma US, Inc. v. Delcor Asset Corporation

1:15-cv-01210

Overview

Case Number 1:15-cv-01210
Filing Date 2015-12-27
Status Terminated
Termination Date 2016-04-19
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Renaissance Acquistion Holdings, LLC NPE (Patent Assertion Entity)

Represented By

0 Attorneys Listed
No attorneys available

Renaissance Pharma, Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Delcor Asset Corporation NPE (Individual / Inventor)

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Aptalis Pharma Canada ULC Operating Company

Represented By

2 Attorneys Listed

Amy Michele Dudash

Morgan Lewis & Bockius LLP

Tel: +1 (302) 574-7293

1007 Orange Street, Suite 501

Colm F. Connolly

Morgan Lewis & Bockius LLP

Tel: +1 (302) 574-3000
Fax: +1 (302) 574-3001

1007 Orange Street, Suite 501

Aptalis Pharma US, Inc. Operating Company

Represented By

2 Attorneys Listed

Amy Michele Dudash

Morgan Lewis & Bockius LLP

Tel: +1 (302) 574-7293

1007 Orange Street, Suite 501

Colm F. Connolly

Morgan Lewis & Bockius LLP

Tel: +1 (302) 574-3000
Fax: +1 (302) 574-3001

1007 Orange Street, Suite 501

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 6 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (6): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7541384
Mesalamine suppository
Filed: 2008-10-03
Issued: 2009-06-02
Active (1.9 yrs remaining)
Expires: 2028-10-03
US8217083
Mesalamine suppository
Filed: 2009-06-01
Issued: 2012-07-10
Active (2.4 yrs remaining)
Expires: 2029-04-24
US8436051
Mesalamine suppository
Filed: 2009-12-16
Issued: 2013-05-07
Active (2.8 yrs remaining)
Expires: 2029-09-11

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(17 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT - filed against Delcor Asset Corporation, Renaissance Acquistion Holdings, LLC, Renaissance Pharma, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1849960.) - filed by Aptalis Pharma US, Inc., Aptalis Pharma Canada ULC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(rwc) (Entered: 12/28/2015)

Entry #1 • 2015-12-27
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT - filed against Delcor Asset Corporation, Renaissance Acquistion Holdings, LLC, Renaissance Pharma, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1849960.) - filed by Aptalis Pharma US, Inc., Aptalis Pharma Canada ULC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(rwc) (Entered: 12/28/2015)

Entry #1 • 2015-12-27
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT - filed against Delcor Asset Corporation, Renaissance Acquistion Holdings, LLC, Renaissance Pharma, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1849960.) - filed by Aptalis Pharma US, Inc., Aptalis Pharma Canada ULC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(rwc) (Entered: 12/28/2015)

Entry #1 • 2015-12-27
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT - filed against Delcor Asset Corporation, Renaissance Acquistion Holdings, LLC, Renaissance Pharma, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1849960.) - filed by Aptalis Pharma US, Inc., Aptalis Pharma Canada ULC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(rwc) (Entered: 12/28/2015)

Entry #1 • 2015-12-27
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT - filed against Delcor Asset Corporation, Renaissance Acquistion Holdings, LLC, Renaissance Pharma, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1849960.) - filed by Aptalis Pharma US, Inc., Aptalis Pharma Canada ULC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(rwc) (Entered: 12/28/2015)

Entry #1 • 2015-12-27
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc